---
$id: https://graph.org.ai/products/commodity/51112017
$type: Product
source: UNSPSC
code: "51112017"
title: "Sunitinib malate"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sunitinib malate

**UNSPSC Code**: 51112017
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor and angiogenesis activator inhibitor with the molecular formula C22H27FN4O2.C4H6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LVX8N1UT73. European Medicines Agency schedules sunitinib malate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22366. The term sunitinib malate is a United States Adopted Name designation. As of Q4 2014, SUNITINIB MALATE remains US FDA's Preferred Term for this commodity. Sunitinib malate bears US NLM identifiers UMLS ID C1700685 and NCI Concept Code C26673. Most nations, for tariff and trade purposes, schedule sunitinib malate under HS 29337900 and SITC 51561. SMILES: CCN(CC)CCNC(=O)C1C(C([NH]C1C)/C=C\2/C3CC(CCC3NC2=O)F)C.C([C@@H](C(=O)O)O)C(=O)O.

